1
de Wild, Sabine R., de Munck, Linda, Simons, Janine M., Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H.M., Houben, Ruud M.A., van Leeuwen, A. Elise, Linn, Sabine C., Pijnappel, Ruud M., Poortmans, Philip M.P., Strobbe, Luc J.A., Wesseling, Jelle, Voogd, Adri C., Boersma, Liesbeth J.
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
2
Eijkelboom, Anouk H., de Munck, Linda, Vrancken Peeters, Marie Jeanne T.F.D., Broeders, Mireille J.M., Strobbe, Luc J.A., Bos, Monique E.M.M., Schmidt, Marjanka K., Guerrero Paez, Cristina, Smidt, Marjolein L., Bessems, Maud, Verloop, Janneke, Linn, Sabine, Lobbes, Marc B.I., Honkoop, Aafke H., van den Bongard, Desirée H.J.G., Westenend, Pieter J., Wesseling, Jelle, Menke-van der Houven van Oordt, C. Willemien, Tjan-Heijnen, Vivianne C.G., Siesling, Sabine
Veröffentlicht in: Eijkelboom , A H , de Munck , L , the NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium , Vrancken Peeters , M J T F D , Broeders , M J M , Strobbe , L J A , Bos , M E M M , Schmidt , M K , Guerrero Paez , C , Smidt , M L , Bessems , M , Verloop , J , Linn , S , Lobbes , M B I , Honkoop , A H , van den Bongard , D H J G , Westenend , P J , Wesseling , J , Menke-van der Houven van Oordt , C W , Tjan-Heijnen , V C G & Siesling , S 2021 , ' Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands : a population-based study ' , Journal of Hematology and Oncology , vol. 14 , no. 1 , 64 . https://doi.org/10.1186/s13045-021-01073-7;
2021
Veröffentlicht in: Eijkelboom , A H , de Munck , L , the NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium , Vrancken Peeters , M J T F D , Broeders , M J M , Strobbe , L J A , Bos , M E M M , Schmidt , M K , Guerrero Paez , C , Smidt , M L , Bessems , M , Verloop , J , Linn , S , Lobbes , M B I , Honkoop , A H , van den Bongard , D H J G , Westenend , P J , Wesseling , J , Menke-van der Houven van Oordt , C W , Tjan-Heijnen , V C G & Siesling , S 2021 , ' Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands : a population-based study ' , Journal of Hematology and Oncology , vol. 14 , no. 1 , 64 . https://doi.org/10.1186/s13045-021-01073-7;
2021